Intervention name : Rontalizumab Dosage And administration of the intervention : Single and multiple subcutaneous administration of 3 different doses of rontalizumab Control intervention name : null Intervention name : Rontalizumab Dosage And administration of the intervention : Single and multiple ...
A Study to Evaluate the Efficacy and Safety of Rontalizumab in Patients With Moderately to Severely Active Systemic Lupus Erythematosus A Study to Evaluate the Efficacy and Safety of Rontalizumabin Patients With Moderately to Severely A ...
A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rontalizumab (rhuMAb IFNalpha) in Patients With Moderately to Severely Active Systemic Lupus Erythematosus A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety o ...
Systemic Lupus Erythematosus
Drug: Placebo;Drug: Rontalizumab
Genentech, Inc.
NULL
Completed
18 Years
65 Years
Both
238
Phase 2
United States;Argentina;Colombia;Mexico;Poland;Russian Federation;United Kingdom